Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer

References

• KollerMBarsukDZippelDEngelbergSBen-AriGPapaMZSentinel lymph node involvement – a predictor for axillary node status with breast cancer – has the time come?Eur J Surg Oncol19982431661689630852
   PubMedGoogle Scholar
• AhmedMPurushothamADDouekMNovel techniques for sentinel lymph node biopsy in breast cancer: a systematic reviewLancet Oncol2014158e351e36224988938
   PubMed Web of Science ®Google Scholar
• SingletarySESystemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why?J Am Coll Surg2001192222023011220722
   PubMed Web of Science ®Google Scholar
• LandSRKopecJAJulianTBPatient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32J Clin Oncol201028253929393620679600
   PubMed Web of Science ®Google Scholar
• GiulianoAEMcCallLBeitschPLocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trialAnn Surg2010252342643220739842
   PubMed Web of Science ®Google Scholar
• LymanGHGiulianoAESomerfieldMRAmerican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancerJ Clin Oncol200523307703772016157938
   PubMed Web of Science ®Google Scholar
• VeronesiUPaganelliGVialeGA randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerN Engl J Med2003349654655312904519
   PubMed Web of Science ®Google Scholar
• KragDWeaverDAshikagaTThe sentinel node in breast cancer – a multicenter validation studyN Engl J Med1998339149419469753708
   PubMed Web of Science ®Google Scholar
• KuwajerwalaNKFeczkoCDekhneNComparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymph node biopsy followed by immediate and delayed ALNDAm J Clin Oncol2013361202322157215
   PubMed Web of Science ®Google Scholar
• ManselREFallowfieldLKissinMRandomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC TrialJ Natl Cancer Inst2006981259960916670385
   PubMedGoogle Scholar
• SchwartzGFGiulianoAEVeronesiUProceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breastBreast J20028126138
   Google Scholar
• HarlowSPKragDNJulianTBPrerandamization Surgical Training for National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancerAnn Surg20052411485415621990
   PubMed Web of Science ®Google Scholar
• TreselerPPathologic examination of the sentinel lymph node: what is the best method?Breast J200612suppl 2S143S15116958994
   PubMedGoogle Scholar
• PargaonkarASBeissnerRSSnyderSEvaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancerArch Pathol Lab Med2003127670170512741893
   PubMed Web of Science ®Google Scholar
• WeaverDLKragDNMannaEADetection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer: an NSABP Protocol B-32 Quality Assurance StudyCancer2006107466166717024757
   PubMed Web of Science ®Google Scholar
• WadaNImotoSHasebeTEvaluation of intraoperative section diagnosis of sentinel lymph nodes in breast cancerJpn J Clin Oncol200434311311715078905
   PubMed Web of Science ®Google Scholar
• TsujimotoMNakabayashiKYoshidomeKOne-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patientsClin Cancer Res200713164807481617699859
   PubMed Web of Science ®Google Scholar
• KimSJIkedaNShibaETakamuraYNoguchiSDetection of breast cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistryBreast Cancer200181636911180768
   PubMedGoogle Scholar
• NakamuraTYasumuraTHayashiKImmunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separationAnticancer Res2000206C4739474411205210
   PubMed Web of Science ®Google Scholar
• OyaizuNKozaiYKodoHA case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytesActa Haematol2005113319419715870490
   PubMed Web of Science ®Google Scholar
• PaiRKWestRBMOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray studyAppl Immunohistochem Mol Morphol200917320220619391212
   PubMedGoogle Scholar
• PuRTPangYMichaelCWUtility of WT-1, p63. MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in infusionDiagn Cytopathol2007361202518064689
   PubMed Web of Science ®Google Scholar
• KimMJShinHCShinKCBest immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimensAnn Diagn Pathol2013171859023040737
   PubMed Web of Science ®Google Scholar
• PargaonkarASBeissnerRSSnyderSSpeightsVOJrEvaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancerArch Pathol Lab Med2003127670170512741893
   PubMed Web of Science ®Google Scholar
• ApostolopoulosVPieterszGAMcKenzieIFMUC1 and breast cancerCurr Opin Mol Ther1999119810311249691
   PubMedGoogle Scholar
• SenapatiSDasSBatraSKMucin-interacting proteins: from function to therapeuticsTrends Biochem Sci201035423624519913432
   PubMed Web of Science ®Google Scholar
• KufeDWMucins in cancer: function, prognosis and therapyNat Rev Cancer200991287488519935676
   PubMed Web of Science ®Google Scholar
• HamadaTNomuraMKamikawaYDF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinomaCancer2012118215251526422434549
   PubMed Web of Science ®Google Scholar
• OkayamaHKumamotoKSaitouKCD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancerOncol Rep200922474575519724852
   PubMed Web of Science ®Google Scholar
• TempferCLöschAHeinzlHPrognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancerEur J Cancer199632A11202320258943691
   PubMed Web of Science ®Google Scholar